FTDI
First Trust Direct Indexing’s West Pharmaceutical WST Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-3,511
| Closed | -$1.05M | – | 942 |
|
2024
Q3 | $1.05M | Buy |
3,511
+683
| +24% | +$205K | 0.06% | 330 |
|
2024
Q2 | $932K | Sell |
2,828
-21
| -0.7% | -$6.92K | 0.06% | 327 |
|
2024
Q1 | $1.13M | Buy |
2,849
+275
| +11% | +$109K | 0.08% | 271 |
|
2023
Q4 | $906K | Buy |
2,574
+63
| +3% | +$22.2K | 0.08% | 288 |
|
2023
Q3 | $942K | Buy |
2,511
+386
| +18% | +$145K | 0.11% | 216 |
|
2023
Q2 | $813K | Sell |
2,125
-160
| -7% | -$61.2K | 0.09% | 268 |
|
2023
Q1 | $792K | Sell |
2,285
-118
| -5% | -$40.9K | 0.09% | 271 |
|
2022
Q4 | $566K | Buy |
2,403
+221
| +10% | +$52K | 0.08% | 347 |
|
2022
Q3 | $537K | Sell |
2,182
-35
| -2% | -$8.61K | 0.08% | 326 |
|
2022
Q2 | $670K | Buy |
2,217
+56
| +3% | +$16.9K | 0.09% | 277 |
|
2022
Q1 | $888K | Buy |
2,161
+103
| +5% | +$42.3K | 0.11% | 245 |
|
2021
Q4 | $965K | Sell |
2,058
-73
| -3% | -$34.2K | 0.13% | 193 |
|
2021
Q3 | $905K | Buy |
2,131
+1,154
| +118% | +$490K | 0.13% | 199 |
|
2021
Q2 | $351K | Buy |
+977
| New | +$351K | 0.05% | 425 |
|
2021
Q1 | – | Sell |
-116
| Closed | -$33K | – | 1005 |
|
2020
Q4 | $33K | Buy |
+116
| New | +$33K | 0.01% | 827 |
|